- ISIN
- US4500561067
- CUSIP
- 450056106
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Oct 20, 2016
Highlights
- Market Cap
- $3.40B
- Enterprise Value
- $3.90B
- EPS (TTM)
- -$0.85
- Total Revenue (TTM)
- $787.85M
- Gross Profit (TTM)
- $559.39M
- EBITDA (TTM)
- -$3.10M
- Year Range
- $101.75 - $212.00
- Target Price
- $209.50
- ROA (TTM)
- -2.76%
- ROE (TTM)
- -17.23%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
IRTC Performance Chart
iRhythm Technologies, Inc. (IRTC) is down 41.1% since the beginning of the year. At $105 per share, IRTC is trading 50.7% below its 52-week high of $212. Investors who bought $1,000 worth of IRTC shares 5 years ago would now be looking at an investment worth $1,684.
Loading charts...
Returns By Period
iRhythm Technologies, Inc. (IRTC) has returned -41.07% so far this year and -27.88% over the past 12 months.
iRhythm Technologies, Inc.
- 1D
- -0.89%
- 1M
- -12.27%
- YTD
- -41.07%
- 6M
- -42.88%
- 1Y
- -27.88%
- 3Y*
- -0.35%
- 5Y*
- 10.99%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
IRTC Monthly Returns History
Based on dividend-adjusted daily data since Oct 20, 2016, IRTC's average daily return is +0.13%, while the average monthly return is +2.47%. At this rate, an investment would double in approximately 2.4 years.
Historically, 52% of months were positive and 48% were negative. The best month was Aug 2020 with a return of +76.9%, while the worst month was Apr 2021 at -43.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.
On a daily basis, IRTC closed higher 50% of trading days. The best single day was Nov 3, 2021 with a return of +59.0%, while the worst single day was Apr 12, 2021 at -39.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -12.92% | -13.44% | -11.76% | 9.44% | -11.81% | -8.20% | -41.07% | ||||||
| 2025 | 20.72% | 1.20% | -4.97% | 2.11% | 31.44% | 9.58% | -8.95% | 21.26% | 1.18% | 8.90% | 0.38% | -5.62% | 96.78% |
| 2024 | 11.90% | -0.94% | -2.23% | -5.53% | -19.50% | 22.03% | -19.87% | -17.82% | 4.74% | -2.42% | 20.05% | 3.69% | -15.76% |
| 2023 | 4.94% | 19.72% | 5.40% | 5.94% | -13.04% | -8.71% | 0.71% | -1.61% | -8.81% | -16.70% | 8.61% | 25.52% | 14.27% |
| 2022 | 6.07% | 3.56% | 21.81% | -21.65% | 14.17% | -23.30% | 43.14% | -4.64% | -15.04% | 1.76% | -14.46% | -14.10% | -20.41% |
| 2021 | -29.00% | -4.47% | -13.70% | -43.93% | -3.08% | -12.07% | -22.95% | -6.49% | 22.51% | 19.77% | 50.56% | 11.45% | -50.39% |
Benchmark Metrics
iRhythm Technologies, Inc. has an annualized alpha of 17.24%, beta of 1.16, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since October 21, 2016.
- This stock captured 103.02% of S&P 500 Index gains but only 96.78% of its losses - a favorable profile for investors.
- R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 17.24%
- Beta
- 1.16
- R²
- 0.12
- Upside Capture
- 103.02%
- Downside Capture
- 96.78%
Return for Risk
Risk / Return Rank
IRTC ranks 15 for risk / return — in the bottom 15% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for iRhythm Technologies, Inc. (IRTC) and compare them to S&P 500 Index.
| IRTC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.90 | ||
| Sortino ratioReturn per unit of downside risk | -3.90 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 1.41 | -0.50 |
| Calmar ratioReturn relative to maximum drawdown | -0.63 | 2.93 | -3.55 |
| Martin ratioReturn relative to average drawdown | -1.33 | 13.52 | -14.85 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the iRhythm Technologies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the iRhythm Technologies, Inc. was 84.39%, occurring on Aug 19, 2021. The portfolio has not yet recovered.
The current iRhythm Technologies, Inc. drawdown is 61.05%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2021 bear market2021 | -84.39%Aug 2021 | 7mo | — | 5y 4moJan 2021 - now |
COVID crash2020 | -43.01%Mar 2020 | 12d | 1mo 12d | 1mo 24dMar 2020 - Apr 2020 |
Rate-hike selloffLate 2018 | -37.92%Dec 2018 | 3mo 8d | 2mo 7d | 5mo 15dSep 2018 - Mar 2019 |
2019 bear market2019 | -37.33%Dec 2019 | 9mo 21d | 2mo 15d | 1y 1dMar 2019 - Mar 2020 |
2020 bear market2020 | -30.77%Dec 2020 | 18d | 1mo 17d | 2mo 5dNov 2020 - Jan 2021 |
Drawdown Indicators
| IRTC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.39% | -56.78% | -27.61% |
Max Drawdown (1Y)Largest decline over 1 year | -44.75% | -9.10% | -35.65% |
Max Drawdown (3Y)Largest decline over 3 years | -53.83% | -18.90% | -34.93% |
Max Drawdown (5Y)Largest decline over 5 years | -66.03% | -25.43% | -40.60% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -61.05% | -0.74% | -60.31% |
Average DrawdownAverage peak-to-trough decline | -37.05% | -10.72% | -26.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.99% | 1.97% | +19.02% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of iRhythm Technologies, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how iRhythm Technologies, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for IRTC relative to other companies in the Medical Devices industry. Currently, IRTC has a P/S ratio of 4.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IRTC in comparison with other companies in the Medical Devices industry. Currently, IRTC has a P/B value of 21.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with IRTC
Add iRhythm Technologies, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with IRTC